Women's Health

Call today to schedule your mammogram:

800-424-DOCS


blog image
Women's Health

Exposure to fine-particle air pollution linked to dense breast tissue, a risk factor for tumors, study finds

Read more
blog image
Women's Health

New research might shed light on why women struggle with weight more than men do

Read more
blog image
Women's Health

Study found life expectancy differed by as much as 20 years in different counties

Read more
blog image
Women's Health

Study finds that most still recommend the breast cancer screen for women in their early 40s

Read more

Zejula Approved for Certain Female Cancers

TUESDAY, March 28, 2017 -- Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurring cancers of the ovaries, fallopian tubes or abdominal wall (peritoneum) whose tumors have shrunk in response to platinum-based chemotherapy.

Citing the National Cancer Institute, the FDA said in a news release that more than 22,000 women are expected to be diagnosed with these cancers this year, and more than 14,000 will die of these diseases.

Read more